BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1850690)

  • 1. Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid.
    Tsai BS; Kessler LK; Stolzenbach J; Schoenhard G; Bauer RF
    Dig Dis Sci; 1991 May; 36(5):588-93. PubMed ID: 1850690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-type prostaglandin binding sites in isolated canine parietal cells: elucidation with (3H) misoprostol free acid.
    Tsai BS; Kessler LK; Schoenhard G; Collins PW; Bauer RF
    Z Gastroenterol; 1987 Apr; 25(4):201-6. PubMed ID: 2884786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of specific E-type prostaglandin receptors using enriched preparations of canine parietal cells and [3H]misoprostol free acid.
    Tsai BS; Kessler LK; Schoenhard G; Collins PW; Bauer RF
    Am J Med; 1987 Jul; 83(1A):9-14. PubMed ID: 2887113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
    Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
    J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisecretory activity of misoprostol, its racemates, stereoisomers and metabolites in isolated parietal cells.
    Tsai BS; Kessler LK; Collins P; Kramer S; Bauer RF
    Prostaglandins; 1987; 33 Suppl():30-9. PubMed ID: 2827238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of misoprostol on histamine-stimulated acid secretion and cyclic AMP formation in isolated canine parietal cells.
    Tsai BS; Kessler LK; Butchko GM; Bauer RF
    Dig Dis Sci; 1987 Sep; 32(9):1010-6. PubMed ID: 3040357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular coupling of prostaglandin inhibition of acid secretion in isolated rabbit gastric parietal cells.
    Choquet A; Leonard A; Magous R; Bali JP
    Biochem Pharmacol; 1990 Jun; 39(12):1905-11. PubMed ID: 1693850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective on the gastric antisecretory effects of misoprostol in man.
    Dajani EZ
    Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pepsin release by prostaglandin E1 analogue. A potential therapeutic problem.
    Basson MD; Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Arch Surg; 1988 Apr; 123(4):431-3. PubMed ID: 3126724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
    Wilson DE
    Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misoprostol: a prostaglandin E1 analog with antisecretory and cytoprotective properties.
    Jones JB; Bailey RT
    DICP; 1989 Apr; 23(4):276-82. PubMed ID: 2499129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SC-46275: a potent, long-acting gastric antisecretory prostaglandin with low oral bioavailability in the dog.
    Perkins WE; Burton EG; Tsai BS; Collins PW; Casler JJ; Gasiecki AF; Bauer RF; Jones PH; Gaginella TS
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1004-7. PubMed ID: 1762057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misoprostol: a prostaglandin for peptic ulcer.
    DiPalma JR
    Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of prostaglandin E receptors in canine small intestine using [3H] prostaglandin E1 binding.
    Keith RH; Tsai BS; Collins PW; Perkins WE; Shone RL; Gasiecki AF; Bianchi RG; Bauer RF
    Prostaglandins; 1992 Dec; 44(6):579-95. PubMed ID: 1335587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E analogue inhibition of intrinsic factor release.
    Zucker KA; Adrian TE; Ballantyne GH; Modlin IM
    Scand J Gastroenterol; 1988 Aug; 23(6):650-4. PubMed ID: 3140367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol preclinical pharmacology.
    Bauer RF
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):118S-125S. PubMed ID: 3932042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins and the dog stomach: effects of misoprostol on the proportion of mucosa to muscle and on the proportion of different epithelial cell types.
    Goodlad RA; Madgwick AJ; Moffatt MR; Levin S; Allen JL; Wright NA
    Digestion; 1990; 45(4):212-6. PubMed ID: 2119321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry and synthetic development of misoprostol.
    Collins PW; Pappo R; Dajani EZ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):114S-117S. PubMed ID: 3932041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of rioprostil with the parietal cell prostaglandin E2 receptor.
    Beinborn M; Nüstedt V; Sewing KF
    Scand J Gastroenterol Suppl; 1989; 164():21-4; discussion 24-5. PubMed ID: 2554487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of misoprostol on gastric acid secretion in vitro. Qualitative differences from natural prostaglandins.
    Bertaccini G; Adami M; Coruzzi G
    Dig Dis Sci; 1988 Oct; 33(10):1265-8. PubMed ID: 3139378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.